↓ Skip to main content

Dove Medical Press

Liraglutide and obesity: a review of the data so far

Overview of attention for article published in Drug Design, Development and Therapy, March 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent
3 patents

Readers on

mendeley
255 Mendeley
Title
Liraglutide and obesity: a review of the data so far
Published in
Drug Design, Development and Therapy, March 2015
DOI 10.2147/dddt.s58459
Pubmed ID
Authors

Ellen E Ladenheim

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Austria 1 <1%
United Kingdom 1 <1%
Denmark 1 <1%
Russia 1 <1%
Unknown 250 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 39 15%
Student > Ph. D. Student 34 13%
Student > Master 34 13%
Researcher 26 10%
Student > Postgraduate 13 5%
Other 40 16%
Unknown 69 27%
Readers by discipline Count As %
Medicine and Dentistry 58 23%
Pharmacology, Toxicology and Pharmaceutical Science 30 12%
Biochemistry, Genetics and Molecular Biology 20 8%
Agricultural and Biological Sciences 17 7%
Nursing and Health Professions 9 4%
Other 38 15%
Unknown 83 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2022.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#642
of 2,268 outputs
Outputs of similar age
#93,785
of 270,996 outputs
Outputs of similar age from Drug Design, Development and Therapy
#24
of 70 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,996 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.